Scarica l'app Stockscreener
1.65
1.79%
-0.03
Dopo l'orario di chiusura:
1.76
0.11
+6.67%
Precedente Chiudi:
$1.68
Aprire:
$1.7
Volume 24 ore:
213.16K
Relative Volume:
0.53
Capitalizzazione di mercato:
$79.81M
Reddito:
$1.82M
Utile/perdita netta:
$-267.63M
Rapporto P/E:
-0.0818
EPS:
-20.1639
Flusso di cassa netto:
$-50.53M
1 W Prestazione:
+7.14%
1M Prestazione:
+10.00%
6M Prestazione:
-29.49%
1 anno Prestazione:
-82.45%
Intervallo 1D:
$1.65
$1.755
Intervallo di 1 settimana:
$1.52
$1.755
Portata 52W:
$1.38
$10.76
Cibus Inc Stock (CBUS) Company Profile
Nome
Cibus Inc
Settore
Industria
Telefono
(858) 450-0008
Indirizzo
6455 NANCY RIDGE DRIVE, SAN DIEGO
Confronta CBUS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.65 | 74.52M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-29 | Iniziato | Alliance Global Partners | Buy |
| 2024-07-19 | Ripresa | Canaccord Genuity | Buy |
| 2023-10-09 | Iniziato | H.C. Wainwright | Buy |
| 2023-07-19 | Ripresa | Canaccord Genuity | Buy |
Cibus Inc Borsa (CBUS) Ultime notizie
What analysts say about Cibus Inc. stockRapid wealth creation - Autocar Professional
Is Cibus Inc. a good long term investmentExtraordinary profit generation - PrintWeekIndia
What drives Cibus Inc. stock priceOverwhelming profit margins - Autocar Professional
Cibus Inc. Stock Analysis and ForecastDynamic capital growth - jammulinksnews.com
Cibus Inc. shares fall 4.76% after-hours despite Pareto Securities raising price target to SEK 215. - AInvest
What makes Cibus Inc. stock price move sharplySteady Profit Stock Forecasts - beatles.ru
Cibus Inc. shares rise 1.22% after-hours after acquiring ten properties for over SEK 400 million. - AInvest
How Cibus Inc. stock performs during market volatilityPredictable Return Stock Picks - Newser
Why Cibus Inc. stock attracts strong analyst attentionShort Term Risk Controlled Alerts - Newser
Cibus (NASDAQ:CBUS) & Cadiz (NASDAQ:CDZI) Head to Head Survey - Defense World
US FDA Completes Review of Altered Lignin Alfalfa Developed by Cibus and S&W Seed - ISAAA.org
Cibus, Inc.(NasdaqCM: CBUS) dropped from Russell 3000E Index - MarketScreener
FDA completes review of altered lignin alfalfa - Agri-Pulse
First Gene-Edited Alfalfa Gets FDA Green Light: Cibus Ready for Commercial Launch - Stock Titan
Cibus and John Innes Centre announce ongoing collaboration with potential to revolutionise fertilizer use in farming - World Fertilizer
Financial Metrics Exploration: Understanding Cibus Inc (CBUS) Through Ratios - DWinneX
Two Sigma Investments LP Purchases New Holdings in Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus Slides on Alliance with John Innes Centre - Baystreet.ca
Cibus (CBUS) Expands Collaboration with John Innes Centre for Cr - GuruFocus
Cibus (CBUS) Expands Collaboration with John Innes Centre for Crop Innovation | CBUS Stock News - GuruFocus
Cibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize Fertilizer Use in Farming - The Manila Times
Cibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize ... - Leader-Telegram
Agricultural Breakthrough: Scientists Find Gene Mutation That Could Transform Farming Economics - Stock Titan
USDA-APHIS Designates Cibus's Herbicide Tolerance Canola Trait HT2 as Not Regulated - ISAAA.org
Millennium Management LLC Sells 15,409 Shares of Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus, Inc. Announces Closing of $27.5 Million Public Offering - The Manila Times
Cibus, Inc. Announces Closing of $27.5 Million Public Offering | - GuruFocus
Cibus, Inc. Closes $27.5 Million Public Offering of Class A Common Stock - Nasdaq
Agricultural Biotech Cibus Secures $27.5M Investment to Advance Gene Editing Platform - Stock Titan
CBUS ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Cibus, Inc. Shareholders Who Lost Money - ACCESS Newswire
Hogs Look to New Week Following Friday Strength - The Globe and Mail
Jane Street Group LLC Takes Position in Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus, Inc. Announces Closing of $27.5 Million Public Offering | CBUS Stock News - GuruFocus
Cibus says USDA designates HT2 as ‘not regulated’ under biotech regulations - Yahoo Finance
Nuveen Asset Management LLC Has $106,000 Position in Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus Canola Trait Gains USDA Non-Regulated Status By Investing.com - Investing.com South Africa
Cibus Announces Public Offering of Common Stock - TipRanks
Cibus Stock (CBUS) Plummets 30% on Public Offering Pricing - The Globe and Mail
Cibus stock rises on USDA deregulation of new canola trait By Investing.com - Investing.com Nigeria
Cibus Inc Azioni (CBUS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.87%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):